This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pal, J. K. Articles by Sarino, W. A. Search for Related Content PubMed PubMed Citation Articles by Pal, J. K. Articles by Sarino, W. A. Related Collections Pharmacology Psychosis

Effect of Risperidone on Prolactinoma Growth in a Psychotic Woman

From the Department of Psychiatry, Mt. Sinai Hospital, Chicago and Finch University of Health Sciences/The Chicago Medical School, North Chicago, IL.

Address reprint requests to: Jayanta K. Pal, MD, 4825 Kirk St., Apt. 2N, Skokie, IL 60077.

OBJECTIVE: The case of a psychotic woman is described in which risperidone use was found to correspond with an increase in the size of a prolactinoma and prevented the return of serum prolactin level to baseline.

METHODS: Although the patient had been treated with a high dose of bromocriptine, her prolactin level remained elevated, causing persistent galactorrhea. The patient later was treated with olanzapine and carbamazepine successfully.

RESULTS: This case report highlights the role of risperidone on prolactin and discusses alternative methods of treating psychosis when the etiology is unclear, especially in younger patients.

CONCLUSIONS: The authors recommend that additional studies regarding the relationship between the growth of prolactinoma and atypical antipsychotics would be worthwhile.

Key Words: psychosis • prolactinoma • atypical antipsychotic.

Abbreviations: D2 = dopaminergic; EEG = electroencephalogram; MRI = magnetic resonance imaging; GABA = gamma-aminobutyric acid.

This article has been cited by other articles:

				C Akkaya, B Kaya, Z Kotan, A Sarandol, C Ersoy, and S Kirli Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases J Psychopharmacol, August 1, 2009; 23(6): 723 - 726. [Abstract] [PDF]

				R. I. Holt Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists J Psychopharmacol, March 1, 2008; 22(2_suppl): 28 - 37. [Abstract] [PDF]

				A. R. Kunwar and J. L Megna Resolution of Risperidone-Induced Hyperprolactinemia with Substitution of Quetiapine Ann. Pharmacother., February 1, 2003; 37(2): 206 - 208. [Abstract] [Full Text] [PDF]